| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361662 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2356109C Insulin-like growth factor (igf) i mutant variants |
| 04/22/2008 | CA2297082C Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/22/2008 | CA2223056C Prepackaged therapeutic meal |
| 04/17/2008 | WO2008046087A2 Spiro compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046065A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008045739A1 Meal replacement compositions and weight control method |
| 04/17/2008 | WO2008045566A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045484A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | WO2008045358A1 Porphyrin catalysts and methods of use thereof |
| 04/17/2008 | WO2008044777A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 04/17/2008 | WO2008044770A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044762A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | WO2008044731A1 N-phenyloxamidic acid derivative |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008044127A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043246A1 Drug composition for treating 2 type diabetes and its chronicity neopathy |
| 04/17/2008 | WO2008043243A1 Use of hydrochloric acid in manufacture of medicament for treating disease caused by fouling of transport tract |
| 04/17/2008 | WO2008024390A3 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 04/17/2008 | WO2008019372A3 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 04/17/2008 | WO2008017398A3 Polymorphic forms of rosiglitazone base |
| 04/17/2008 | WO2008013660A3 Inhibitors of advanced glycation end products |
| 04/17/2008 | WO2008010238A3 Antidiabetic azabicyclo [3. 1. 0] hexan compounds |
| 04/17/2008 | WO2008008887A3 Gpr119 agonists for treating metabolic disorders |
| 04/17/2008 | WO2008002568A3 Active agent formulations, methods of making, and methods of use |
| 04/17/2008 | WO2007144084A3 Type-2 diabetes combination wafer |
| 04/17/2008 | WO2007123949A3 Cannabinoid receptor modulators |
| 04/17/2008 | US20080090913 Sphingolipid-Derived Phamaceutical Compositions |
| 04/17/2008 | US20080090905 Antidiabetic agents; insulin resistance; dyslipidemias; dietetics |
| 04/17/2008 | US20080090890 Substituted, bicyclic 8-pyrrolidinobenzimidazoles, methods for their production and their use as medicaments |
| 04/17/2008 | US20080090889 Substituted 2-aminoalkylthiobenzimidazole compounds, pharmaceutical compositions thereof and methods for their use |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090881 Treatment of diabetes with thiazolidinedione and metformin |
| 04/17/2008 | US20080090876 Diacylglycerol o-acyltransferase (DGAT); treating obesity; for example 2-(2,6-diisopropyl-4-methylphenylaminocarbonyl)-3,6-dipentyl-3,6-dihydro-2H-thiopyran |
| 04/17/2008 | US20080090870 Use of 2-(amino-substituted piperidin-1-yl)benzimidazoles as antidiabetic agents, or to treat carbohydrate and lipid metabolic disorders; use in combination with other drugs; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]-benzenesulfonamide or salts for example |
| 04/17/2008 | US20080090869 Antidiabetic agents, carbohydrate and lipid metabolic disorders; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-y]-benzamide trifluoroacetic acid salt for example; use in combination with other drugs |
| 04/17/2008 | US20080090868 Antidiabetic agents; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-(4-Chlorobenzyl)-2-(3-aminopiperidin-1-yl)-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide hydrochloride for example; use in combination with other antidiabetic, antilipemic agents |
| 04/17/2008 | US20080090865 Non-insulin dependent diabetes; agonists of G-protein coupled receptor 40 (GPR40); for example, 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline |
| 04/17/2008 | US20080090864 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090832 Treating a subject with disorders involving amino acid metabolism, in particular, hyperphenylalaninemia, by administering a therapeutically effective amount of tetrahydrobiopterin (BH4) or salt thereof, wherein the BH4 is administered orally once per day; alleviates dietary restrictions |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090810 Thiophene compounds |
| 04/17/2008 | US20080090805 Cb-1 modulating compounds and their use |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090799 2-pyridinecarboxamide derivative having gk-activating effect |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090753 Rapid Acting Injectable Insulin Compositions |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089897 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |
| 04/17/2008 | US20080089876 Mixture comprising an omega three fatty acid, statin, coenzyme Q10, resveratrol, at least one policosanol, pantethine, selenium, and zinc for use in treatment and prevention of diabetes, obesity, hypertension, hyperlipidaemias and hypercholesterolaemias |
| 04/17/2008 | US20080089858 Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
| 04/17/2008 | DE102006048728A1 3-Amino-imidazo{1,2-a]pyridinderivate 3-amino-imidazo {1,2-a] pyridine |
| 04/17/2008 | DE102006048530A1 Zubereitungen zur oralen Aufnahme (II) Preparations for oral administration (II) |
| 04/17/2008 | DE102006021872B4 4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-oxy or substituted mercapto carboxylic acids, process for their preparation and their use as medicaments |
| 04/17/2008 | CA2675518A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666373A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2664934A1 Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664206A1 Meal replacement compositions comprising dha and weight control method |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911756A2 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911462A2 Compositions comprising a sterol absorption inhibitor |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1911445A2 Stable pharmaceutical formulation comprising an HMG-COA reductase inhibitor |
| 04/16/2008 | EP1910400A2 Improved crystalline form of the compound a-348441 |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910375A1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |